Company registration number 11398147 (England and Wales)
STRANGELOVE ON STAGE LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MAY 2025
PAGES FOR FILING WITH REGISTRAR
STRANGELOVE ON STAGE LTD
CONTENTS
Page
Statement of financial position
1
Notes to the financial statements
2 - 3
STRANGELOVE ON STAGE LTD
STATEMENT OF FINANCIAL POSITION
AS AT
31 MAY 2025
31 May 2025
- 1 -
31 May 2025
31 October 2024
Notes
£
£
£
£
Current assets
Debtors
3
1,116,618
1,014,564
Cash at bank and in hand
160,954
1,247,557
1,277,572
2,262,121
Creditors: amounts falling due within one year
4
(111,758)
(3,187,148)
Net current assets/(liabilities)
1,165,814
(925,027)
Capital and reserves
Called up share capital
150
150
Profit and loss reserves
1,165,664
(925,177)
Total equity
1,165,814
(925,027)

For the financial period ended 31 May 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the income statement within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 2 December 2025 and are signed on its behalf by:
D R Luff
Director
Company registration number 11398147 (England and Wales)
STRANGELOVE ON STAGE LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MAY 2025
- 2 -
1
Accounting policies
Company information

Strangelove on Stage Ltd is a private company limited by shares incorporated in England and Wales. The registered office is c/o 3rd Floor, 39 Charing Cross Road, London, WC2H 0AR.

1.1
Reporting period

The company has shortened its financial reporting period from 3 1 October 2025 to 31 May 2025 and as a consequence the financial statements presented show 7 months' activity against 13 months' for the comparative figures showing.

The financial reporting period was shortened so as to capture the p roduction run.

1.2
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.3
Turnover

Turnover is recognised at the fair value of the consideration received for box office, merchandising and associated income and is shown net of VAT and other sales related taxes.

1.4
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.5
Financial instruments

Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any loss arising from impairment are recognised in the profit and loss account in other administrative expenses.

1.6
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.7
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently recoverable is based on taxable profits/losses for the year and the company's claim to relief under the Theatre Tax Relief provisions. Taxable profit/loss differs from net profit/loss as reported in the income statement because it excludes items that are never taxable or deductible.

STRANGELOVE ON STAGE LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 MAY 2025
1
Accounting policies
(Continued)
- 3 -
1.8
Employee benefits

The costs of short-term employee and workers' benefits are recognised as a liability and an expense. The cost of any unused holiday entitlement is recognised in the period in which the services are received. This includes cast and crew who are not engaged under contracts of employment, however Equity-approved contracts are used.

1.9
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

2
Employees

The average monthly number of persons (including directors) employed by the company during the period was:

2025
2024
Number
Number
Total
9
2
3
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
960
131,277
Corporation tax recoverable
1,092,436
644,600
Other debtors
23,222
238,687
1,116,618
1,014,564
4
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
7,750
185,361
Taxation and social security
-
0
96,159
Other creditors
104,008
2,905,628
111,758
3,187,148
2025-05-31 2024-11-01 false false false 02 December 2025 CCH Software CCH Accounts Production 2025.300 No description of principal activity D R Luff P A Myles 11398147 2024-11-01 2025-05-31 11398147 2025-05-31 11398147 2024-10-31 11398147 core:CurrentFinancialInstruments core:WithinOneYear 2025-05-31 11398147 core:CurrentFinancialInstruments core:WithinOneYear 2024-10-31 11398147 core:WithinOneYear 2025-05-31 11398147 core:WithinOneYear 2024-10-31 11398147 core:CurrentFinancialInstruments 2025-05-31 11398147 core:CurrentFinancialInstruments 2024-10-31 11398147 core:ShareCapital 2025-05-31 11398147 core:ShareCapital 2024-10-31 11398147 core:RetainedEarningsAccumulatedLosses 2025-05-31 11398147 core:RetainedEarningsAccumulatedLosses 2024-10-31 11398147 bus:Director1 2024-11-01 2025-05-31 11398147 2023-10-01 2024-10-31 11398147 bus:PrivateLimitedCompanyLtd 2024-11-01 2025-05-31 11398147 bus:SmallCompaniesRegimeForAccounts 2024-11-01 2025-05-31 11398147 bus:FRS102 2024-11-01 2025-05-31 11398147 bus:AuditExemptWithAccountantsReport 2024-11-01 2025-05-31 11398147 bus:Director2 2024-11-01 2025-05-31 11398147 bus:FullAccounts 2024-11-01 2025-05-31 xbrli:pure xbrli:shares iso4217:GBP